FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs | FDA News
For Immediate Release: January 11, 2021 Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph…